definiens: means ( a ) any single product comprising both ( i ) En oblituzumab and ( ii ) one or more other therapies or pharmaceuticall y active compounds or substances not included in th e [COMPANY] Licensed Technology ; ( b ) any sale of th e Product with another therapy(ies ) or product(s ) f or a single invoice price ; or ( c ) any sale of the Produc t as part of a bundle with other therapy(ies ), prod uct(s ) or service(s ) ( i.e., where the Product and such other therapy(ies ), pr oduct(s ) or service(s ) are sold for a single invoice price or where a discount, rebate or other amount that reduces the price of the Product is pro vided in exchange for ( or otherwise conditioned upon ) the pu rchase of such other therapy(ies ), product(s ) or se rvices ), to the extent not described in clause ( a ) or ( b ) . The Enoblituzumab portion of any Combination Product sh all be deemed the and the other portion of such Combination Product [ * * * ] shall be deemed the, and each Combination Product shall be deemed a P roduct hereunder . For the avoidance of doubt, [ * * * ]